Form 4 for MED MEDIFAST INC
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-08 · accession 0001628280-24-010641 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-12 | 2024-03-08 | MED | SCHLACKMAN SCOTT | Dir | M - OptEx | $27.68 | +1,300 | 11.8K | +12% | +$36.0K |
| DM | 2024-03-12 | 2024-03-08 | MED | SCHLACKMAN SCOTT | Dir | S - Sale+OE | $39.44 | -4,053 | 10.5K | -28% | -$159.9K |
| D | 2024-03-12 | 2024-03-08 | MED | SCHLACKMAN SCOTT | Dir | M - OptEx | $0.00 | -1,300 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-08 | M | A | 1,300 | $27.68 | 11,837.71 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-08 | S | D | 2,753 | $39.46 | 7,784.71 | D | — | — | (F1) The price reported in Column 4 is an average price. These shares were acquired in multiple transactions at prices ranging from $39.38 to $39.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote. |
| 3 | Common | Common Stock | 2024-03-08 | S | D | 1,300 | $39.41 | 10,537.71 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-03-08 | M | D | 1,300 | $0.00 | 0 | D | $27.68 · — to 2026-02-04 | 1,300 Common Stock | (F2) The reporting person received 5,000 stock options on February 4, 2016 pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan. These options vested in three equal annual installments beginning on February 4, 2017. |